Identification of a binding site of general anesthetics on the tandem pore domain potassium channels
Identification of a binding site of general anesthetics on the tandem pore domain potassium channels
批准号:
13671567
负责人:
YAMAKURA Tomohiro
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003
中文摘要
ERG 1、ELK 1和KCNQ 2/3电压门控钾通道对所有测试的全身麻醉剂(氟烷、异氟烷、恩氟烷、F3、F6、戊巴比妥、丙泊酚、依托咪酯、阿法沙龙、氯胺酮、乙醇和己醇)的2个最小肺泡浓度(MAC)具有抗性。另一方面,在内向整流钾通道中,GIRK通道被挥发性麻醉药抑制,但不被静脉麻醉药抑制。神经元型GIRK 1/2通道被2 MAC的氟烷、异氟烷、安氟烷和F3抑制,而心脏型GIRK 1/4通道仅被F3抑制。相反,IRK 1和ROMK 1通道对所有测试的麻醉剂完全耐受。氟烷也能抑制m-阿片受体激活的GIRK 2通道的电流反应。因此,在内向整流钾通道中,GIRK通道,特别是由GIRK 2亚基(神经元亚基)组成的通道,被认为对挥发性麻醉剂敏感。一氧化二氮(0.06大气压)轻微但选择性地增强GIRK通道(GIRK 1/2、GIRK 1/4、GIRK 2通道)约10%。由μ-阿片受体激活的GIRK 2通道也被一氧化二氮增强。嵌合和多个氨基酸突变的结果表明,该地区含有跨膜结构域,但不是孔形成结构域,可能参与确定GIRK和IRK通道之间的麻醉敏感性的差异。虽然麻醉剂对GIRK通道功能的抑制不太可能解释麻醉作用,但它可能导致一些兴奋性副作用。
英文摘要
The ERG1,ELK1,and KCNQ2/3 voltage-gated potassium channels were resistant to 2 minimum alveolar concentrations(MAC) of all general anesthetics tested(halothane, isoflurane, enflurane, F3,F6,pentobarbital, propofol, etomidate, alphaxalone, ketamine, ethanol, and hexanol). On the other hand, among inwardly rectifying potassium channels, GIRK channels were inhibited by volatile anesthetics, but not by intravenous anesthetics. The neuronal-type GIRK1/2 channels were inhibited by 2 MAC of halothane, isoflurane, enflurane, and F3, whereas the cardiac-type GIRK1/4 channels were inhibited only by F3. Conversely, IRK1 and ROMK1 channels were completely resistant to all anesthetics tested. Current responses of GIRK2 channels activated by m-opioid receptors were also inhibited by halothane. Thus, among inwardly rectifying potassium channels, GIRK channels, especially those composed of the GIRK2 subunit(neuronal subunit), are suggested to be sensitive to volatile anesthetics. Nitrous oxide (〜0.6 atmosphere) slightly but selectively potentiated GIRK channels(GIRK1/2,GIRK1/4, GIRK2 channels) by 〜10%. GIRK2 channels activated by mu-opioid receptors were also potentiated by nitrous oxide. Results of chimeric and multiple amino acid mutations suggest that the region containing the trans membrane domains, but not the pore-forming domain, may be involved in determining differences in anesthetic sensitivity between GIRK and IRK channels. Although inhibition of GIRK channel function by anesthetics is unlikely to account for the anesthetic actions, it may contribute to some excitatory side effects.
期刊论文(41)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ikeno K, et al.: "The Lurcher mutation reveals Ca^<2+> permeability and PKC modification of the GluRd channels"Neurosci Res. 41(2). 193-200 (2001)
Ikeno K等人:“Lurcher突变揭示了GluRd通道的Ca^2通透性和PKC修饰”Neurosci Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Petrenko AB, et al.: "The role of N-methyl-D-aspartate (NMDA) receptors in pain : A review"Anesth Analg. 97(4). 1108-1116 (2003)
Petrenko AB 等人:“N-甲基-D-天冬氨酸 (NMDA) 受体在疼痛中的作用:综述”Anesth Analg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Zhan RZ, et al.: "Ischemic preconditioning is capable of inducing mitochondrial tolerance in the rat brain"Anesthesiology. 97(4). 896-901 (2002)
Zhan RZ等人:“缺血预处理能够诱导大鼠大脑中的线粒体耐受性”麻醉学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Zhang Y, et al.: "Luciferase as a model for the site of inhaled anesthetic action"Anesth Analg. 93(5). 1246-1252 (2001)
张 Y 等人:“荧光素酶作为吸入麻醉作用部位的模型”Anesth Analg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Petrenko AB, et al.: "Recent Advances in Anaesthesia and Intensive Care"Greenwich Medical Media Limited. 177-207 (2003)
Petrenko AB 等人:“麻醉和重症监护的最新进展”格林威治医疗媒体有限公司。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Molecular mechanisms of gaseous anesthetics on glutamate receptors : Identification of action site and examination of anesthetic behaviors in knock-out mice
-
批准号:13557130
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$2.43万
-
财政年份:2001
-
负责人:YAMAKURA Tomohiro
-
依托单位:
海外基金